ReNeuron Group PLC RQE1-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 9:03 AM CET
1.26UNCH (UNCH)
52 week range
0.75 - 1.90

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.26
  • 52 Week High1.90
  • 52 Week High Date04/14/20
  • 52 Week Low0.75
  • 52 Week Low Date03/24/20
  • Market Cap50.75M
  • Shares Out32.74M
  • 10 Day Average Volume433.33
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-14.58

RATIOS/PROFITABILITY

  • EPS (TTM)-0.49
  • P/E (TTM)-2.57
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest ReNeuron Group PLC News

There is no recent news for this security.

Latest RQE1-FF News From Our Partners

QUOTE FINDER

Profile

MORE
ReNeuron Group plc is a clinical-stage company. The Company, through its subsidiaries, is engaged in researching and developing cell-based therapies. The Company's products are allogeneic. Its CTX stem cell therapy is used for the treatment of patients left disabled by the effects of a stroke. Its human retinal progenitor cells (hRPC) stem cell candidate is used for the treatment of retinitis pigmentosa (RP). Its second CTX stem cell candidate is for the treatment of critical...
Timothy Corn
Non-Executive Chairman
Olav Hellebo
Chief Executive Officer
Michael Hunt
Chief Financial Officer
Shaun Stapleton
Vice President
Address
Pencoed Business Park
Bridgend
CF35 5HY
United Kingdom